The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Does time to progression (TTP) influence post-progression survival (ppOS)?: Analyses from the PointBreak, ECOG 4599, and ARIES studies of bevacizumab in non–small cell lung cancer (NSCLC).
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; Bayer/Onyx; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Millennium
Research Funding - Advantagene (Inst); Ariad (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst)
 
Antoinette J. Wozniak
Honoraria - Biodesix; Xcenda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Novartis
Speakers' Bureau - Biodesix
Research Funding - Astex Pharmaceuticals
 
Mark A. Socinski
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst)
 
Larry Leon
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Research Funding - Genentech
Travel, Accommodations, Expenses - Genentech
 
Shiyao Liu
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Travel, Accommodations, Expenses - Genentech
 
Sebastien Hazard
Employment - Genentech
Stock and Other Ownership Interests - Roche Pharma AG
Travel, Accommodations, Expenses - Genentech
 
Suresh S. Ramalingam
Stock and Other Ownership Interests - Epic Sciences
Honoraria - Boehringer Ingelheim; GlaxoSmithKline; Novartis (I); Roche Pharma AG
Consulting or Advisory Role - Sarah Cannon Research Institute
Research Funding - Boehringer Ingelheim